Welcome to the website of Michael Schlander,

News

2021

Study on "HTA in England, France and Germany"

Comparative study on "Health technology assessment (HTA) in England, France and Germany: What do matched drug pairs tell us about recommendations by national HTA agencies?" in the Journal of Comparative Effectiveness Research (online available as of September 2021).

Read more …

Article on "Resource allocation in the Covid-19 health crisis"

Recently published paper on "Resource allocation in the Covid-19 health crisis: are Covid-19 preventive measures consistent with the Rule of Rescue?" in the scientific journal Medicine, Health Care and Philosophy (online available as of August 2021).

Read more …

How Much Does it Cost to Research and Develop a New Drug?

Recently published: "How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment" in the well-known journal PharmacoEconomics - evaluating the range and suitability of published R&D cost estimates as to the degree to which they represent the actual costs of industry (online available as of August 2021).

Read more …

Study on "Income loss after a cancer diagnosis in Germany"

Recently published study on "Income loss after a cancer diagnosis in Germany: An analysis based on the socio-economic panel survey" in the scientific journal Cancer Medicine, which is the first attempt to measure - on the German national level - the magnitude of absolute income loss after a cancer diagnosis.

Read more …